Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3928studies shown
Showing 1,176-1,200 of 3,928
RecruitingNCT06682689

Investigation of TVNS Administration on Postpartum Mental Health

This study is looking at whether a digital support tool can help people with Postpartum Depression, Postpartum Anxiety, Postpartum Sadness, or Postpartum Blues. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionDeviceOver 18 Years
Countries
Germany
Sponsor
University Hospital Tuebingen
Condition
Depression
RecruitingNCT06512194

Investigation to Understand and Optimize Psilocybin

This study is looking at examine the effects of a single dose of psilocybin, administered with psychological support, on symptoms of depression. Participants receive Psilocybin or Group 2: Psilocybin + Sham taVNS and complete study visits and assessments.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Charles Raison
Condition
Depression
Not Yet RecruitingNCT06920888

Is Less More? Dosing and Sequencing Effect

This study is looking at whether questionnaires and follow-up can help people with Depression/Anxiety. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionBehavioralOver 18 Years
Countries
Global
Sponsor
University of Aarhus
Condition
Depression
RecruitingNCT07003997

JAK Signaling in Depression

This study is comparing Baricitinib with placebo for people with depression. Participants receive Baricitinib or placebo and complete study visits and assessments.

DepressionDrugFrom 25 Years to 55 Years
Countries
United States
Sponsor
Emory University
Condition
Depression
RecruitingNCT05991154

JoyPop Mobile Mental Health App With Indigenous Transitional-Aged Youth

This study is looking at care and outcomes for people with Emotion Regulation, Depression, Anxiety, or Stress. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

DepressionBehavioralFrom 18 Years to 25 Years
Countries
Canada
Sponsor
Lakehead University
Condition
Depression
RecruitingNCT05898516

JoyPop Mobile Mental Health App With Indigenous Youth

This study is looking at care and outcomes for people with Emotion Regulation, Depression, Anxiety, or Stress. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

DepressionBehavioralFrom 12 Years to 17 Years
Countries
Canada
Sponsor
Lakehead University
Condition
Depression
RecruitingNCT06239545

JoyPop Mobile Mental Health App With Transitional-Aged Youth

This study is looking at care and outcomes for people with Emotion Regulation, Depression, Anxiety, or Stress. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

DepressionBehavioralFrom 18 Years to 25 Years
Countries
Canada
Sponsor
Lakehead University
Condition
Depression
RecruitingNCT06239519

JoyPop Mobile Mental Health App With Youth

This study is looking at care and outcomes for people with Emotion Regulation, Depression, Anxiety, or Stress. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

DepressionBehavioralFrom 12 Years to 17 Years
Countries
Canada
Sponsor
Lakehead University
Condition
Depression
RecruitingNCT07129070

Just-in-Time Training for Youth Mentors

This study is looking at whether a digital support tool can help people with Mental Health Issue, Depression, or Anxiety. Participants take part in a digital support tool and complete follow-up assessments.

AnxietyOtherOver 12 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Anxiety
RecruitingNCT02122562

Ketamine Alcohol (in Treatment-Resistant Depression)

This study is looking at whether questionnaires and follow-up can help people with Magnetic Resonance Imaging, Major Depression, or Alcoholism. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Mark Niciu
Condition
Depression
RecruitingNCT07088380

Ketamine Augmentation of ECT in Treatment-Resistant Depression

This study is looking at whether Ketamine Hydrochloride can help people with depression or Treatment Resistant Depression. Participants take part in Ketamine Hydrochloride and complete follow-up assessments.

DepressionDrugFrom 18 Years to 70 Years
Countries
Italy
Sponsor
Università Vita-Salute San Raffaele
Condition
Depression
Not Yet RecruitingNCT07307768

Ketamine Biomarker Validation

25 mg/kg) can help people with Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 18 Years to 59 Years
Countries
United States
Sponsor
Soterix Medical
Condition
Depression
Enrolling By InvitationNCT05565352

Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)

This observational study is following people with depression or anxiety to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionDrugFrom 18 Years to 90 Years
Countries
Poland
Sponsor
Medical University of Gdansk
Condition
Depression
RecruitingNCT06038409

Ketamine Treatment Plans for Chronic Conditions

This observational study is following people with Chronic Pain, depression, anxiety, or Chronic Disease to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
RIVER Foundation
Condition
Depression
Not Yet RecruitingNCT06228391

Ketamine Treatment for PTSD and MDD in TBI

This observational study is following people with PTSD, Post Traumatic Stress Disorder, depression, or Traumatic Brain Injury to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Minneapolis Veterans Affairs Medical Center
Condition
Depression
Not Yet RecruitingNCT06090422

Ketamine for Combined Depression and Alcohol Use Disorder

This study is comparing Ketamine Hydrochloride with Control group for people with Depression or Alcohol Use Disorder. Participants receive Ketamine Hydrochloride or Control group and complete study visits and assessments.

DepressionDrugFrom 18 Years to 65 Years
Countries
Global
Sponsor
University Hospital of North Norway
Condition
Depression
Depression | Clinical Trials | HopeStage Research